Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity

被引:178
作者
Fiore, E
Fusco, C
Romero, P
Stamenkovic, I [1 ]
机构
[1] Massachusetts Gen Hosp, Mol Pathol Unit, Boston, MA 02129 USA
[2] Massachusetts Gen Hosp, MGH Canc Ctr, Boston, MA 02129 USA
[3] Inst Univ Pathol, CH-1011 Lausanne, Switzerland
[4] Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland
关键词
ICAM-1; MMP-9; tumor; proteases; cytotoxicity;
D O I
10.1038/sj.onc.1205684
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Shedding of intercellular adhesion molecule 1 (ICAM-1) is believed to play a role in tumor cell resistance to cell-mediated cytotoxicity. However, the mechanism whereby ICAM-1 is shed from the surface of tumor cells remains unclear. In this study, we have addressed the possibility that matrix metalloproteinases are implicated in ICAM-1 shedding. Our observations suggest a functional relationship between ICAM-1 and matrix metalloproteinase 9 (MMP-9) whereby ICAM-1 provides a cell surface docking mechanism for proMMP-9, which, upon activation, proteolytically cleaves the extracellular domain of ICAM-1 leading to its release from the cell surface. MMP-9-dependent shedding of ICAM-1 is found to augment tumor cell resistance to natural killer (NK) cell-mediated cytotoxicity. Taken together, our observations propose a mechanism for ICAM-1 shedding from the cell surface and provide support for MMP involvement in tumor cell evasion of immune surveillance.
引用
收藏
页码:5213 / 5223
页数:11
相关论文
共 51 条
[1]  
ALTOMONTE M, 1993, CANCER RES, V53, P3343
[2]  
Aoudjit F, 1998, J IMMUNOL, V160, P2967
[3]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[4]  
Becker J C, 1995, Recent Results Cancer Res, V139, P205
[5]  
BECKER JC, 1991, J IMMUNOL, V147, P4398
[6]   Extrinsic regulators of epithelial tumor progression: metalloproteinases [J].
Bergers, G ;
Coussens, LM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (01) :120-127
[7]  
BERNHARD EJ, 1990, CANCER RES, V50, P3872
[8]   DIRECT EVIDENCE LINKING EXPRESSION OF MATRIX METALLOPROTEINASE-9 (92-KDA GELATINASE/COLLAGENASE) TO THE METASTATIC PHENOTYPE IN TRANSFORMED RAT EMBRYO CELLS [J].
BERNHARD, EJ ;
GRUBER, SB ;
MUSCHEL, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4293-4297
[9]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[10]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693